Wed, Mar 4, 2015, 4:38 AM EST - U.S. Markets open in 4 hrs 52 mins

Recent

% | $
Quotes you view appear here for quick access.

pSivida Corp. Message Board

surf5000surf 6 posts  |  Last Activity: Jan 22, 2015 1:02 AM Member since: Jul 22, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    The confirmation that I was waiting for

    by ttbiker2 Jan 21, 2015 7:58 AM
    surf5000surf surf5000surf Jan 22, 2015 1:02 AM Flag

    ttbiker, both me and you have been in this biosphere for some time and I just think we have nailed this Down pretty well, congrats.

  • on you fools, invented trials of 300 mill usd when they both knew it didnt work. Doesnt take a rocket scientist to know that...And Spiro the criminal also prolongs a drug trial facing a rejected drug mixt With his own manure. Criminals

  • Reply to

    A few misconceptions I have read

    by oncology908 Dec 30, 2014 11:12 AM
    surf5000surf surf5000surf Dec 30, 2014 7:58 PM Flag

    Oncology: I was in this play for a loong time and we all knew that Sapa in Aml was the only chance as trials are time consuming and costly. Now this trial is out of the question giving answers to anything just by its design, actually Spiro by deleting the sapa only arm long time ago said this trial is toast, but continued to spend North of 300 mill fueled into the Anderson centre...Sure Hagop and the team buttered their Pockets and thats always healthy..As far as MDS goes there has been drug after drug failing as this condition isnt a neopasi at all, its smouldering of the hemapoetic system affecting all cell ctegories, leading to pan -cytemia. Why should one trust the ph 2 data here when for AML the ph 2 was good and then this #$%$ shot ph 3 ??? And how shall it be financed With a mcap of 16 mill. They would have to print 20 times the current float to accomodate the COSTs. With a mcap like this the pink is approaching, cycc gets nowhere from here and no one Will pay a penny for a failed and useless drug.

  • Reply to

    No safety or efficacy concerns

    by knowfear2015 Dec 29, 2014 5:48 PM
    surf5000surf surf5000surf Dec 29, 2014 8:27 PM Flag

    Yes I fully agree, why should Cyclacel succede, tormenting very old patients without the faintest hope of any success, With a drug nobody cared to do trials on.....At this stage it is an objective truth that the drug does not work, and it does not work in MDS either, period. Spiro is shunning any traial that may set the last nail in the coffin, he knows the drug is toast thats why he "in a hurry" omitted the Sapa only arm.

  • surf5000surf surf5000surf Dec 27, 2014 4:00 PM Flag

    I agree With Jagan here, I too have been in and out in this company and lived through 75 percent of the Deceptions...its like a woman that is unfaithfull but you give her the Benefit of the doubt for too long...like here one doesnt need to see the comp in bed With the pink sheet..Enough is enough, when the ovarian cancer results yielded nothing then one should have walked away. Some obscure insignificant cancer like AML and MDS is where the looser drugs end up, as the solids is where new drugs are really needed. And in solids results just evaporated like for NSCLC and farynx cancer....My advice as both shares have plummeted is to say enough is enough and SELL, and buy Aeterna Zentaris, at least in the latter the ph 3 is still a dream thats not broken yet and its in solid tumors too Endometrial cancer. A swap and a possible recoup. If not a miracle happens its PINKs next for Cycc, dont believe the funds Will be spitting up any more dough.

  • 1) Where are the trials in lung cancer, nasofarynx, and others hidden ?
    2) Why use excesive amounts of money on a cancer that isnt at all responding to any therapy. 300 mill out the window on seamless. Wishfull thinking and wastefull thinking.
    This company has found out nothing, produced not a single successfull trial and is a Complete fraud going on for more than 10 years.

PSDV
4.52+0.02(+0.44%)Mar 3 3:58 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.